Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03847610Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Imperial College London. Primary endpoint: Assessment of the Biosensors Ability to Track Phenoxymethylpenicillin Concentrations Compared to Observations Made by Microdialysis and Blood Sampling at 12 hours. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03847610.